3SOF

Hi Wrangler,

I was watching your pick yesterday.
Still observing your style.
So far so good.
Applaud.

Ares

Quote from: Ares on March 09, 2007, 09:06:00 AM
Hi Wrangler,

I was watching your pick yesterday.
Still observing your style.
So far so good.
Applaud.

Ares

Thanks ares
Got to go for now.
Goodluck trading

Volume wasn't coming in like I like for the beginning of open so I sold @1.35 and will look for pullback.
Watch it be my luck that it will continue to climb

BIOM ; bought @1.07
HYGS : bought @1.05
Both stocks is setting at support and trading on low volume. Will post chart
for both tonight with plan.
Goodluck trading

Here's chart for HYGS,,will post chart for BIOM in a little while   

Quote from: wrangler on March 04, 2007, 12:10:18 AM
Here's chart for PANC. Any questions feel free to ask. This is how I plan my trades

Time for this stock to move. Don't be fooled by what after hours shows on yahoo. Here's afterhours
   
   Panacos Pharmaceuticals, Inc. 

Pre-Market |  After Hours Market    Mar. 12, 2007 Market Close: $ 4.25 
   
   After Hours Trade Reporting Monday March 12   

After Hours
Last: $ 3.79   After Hours
High: $ 4.47 
After Hours
Volume: 20,735   After Hours
Low: $ 3.79

After Hours
Time (ET) After Hours
Price After Hours
Share Volume
16:52   $ 3.79  128
16:37   $ 4  200
16:35   $ 4.20  200
16:35   $ 4.20  100
16:34   $ 4  200
16:28   $ 4.05  100
16:26   $ 4.20  100
16:12   $ 4.29  278
16:12   $ 4.30  100
16:12   $ 4.30  422
16:09   $ 4.26  700
16:09   $ 4.25  800
16:08   $ 4.41  500
16:08   $ 4.41  500
16:06   $ 4.40  100
16:06   $ 4.41  100
16:06   $ 4.47  400
16:04   $ 4.25  1,607
16:04   $ 4.25  100
16:04   $ 4.25  100
16:04   $ 4.29  800
16:04   $ 4.29  100
16:04   $ 4.29  100
16:04   $ 4.29  300
16:04   $ 4.30  700
16:04   $ 4.30  100
16:04   $ 4.30  2,400
16:04   $ 4.30  1,000
16:04   $ 4.30  2,500
16:04   $ 4.30  1,000
16:04   $ 4.30  1,000
16:04   $ 4.30  1,900
16:04   $ 4.30  500
16:04   $ 4.34  100
16:04   $ 4.41  200
16:04   $ 4.44  300
16:04   $ 4.44  500
16:04   $ 4.44  200
16:02   $ 4.23  200
16:02   $ 4.24 




AP
Panacos, FDA Agree on Revised Study
Monday March 12, 5:16 pm ET 
Panacos Pharma to Move on With Studies for Bevirimat After FDA Agreement on Revised Study


WATERTOWN, Mass. (AP) -- Biotechnology company Panacos Pharmaceuticals Inc. said Monday it has agreed with the Food and Drug Administration on a revised trial design for a midstage study of HIV drug candidate bevirimat.
ADVERTISEMENT


The drug previously failed to meet expectations in a midstage study testing a high dose. The next part of the Phase IIb clinical trial will test tolerability and effectiveness at increasing doses using an oral liquid form. Dosing on the next cohort will involve 8 patients on the drug and 2 on placebo, starting at 250 milligrams. The doses will be escalated in later groups by 50 milligrams each following safety reviews.

"Models relating antiviral response to drug levels based on earlier bevirimat clinical data indicated that doses of the liquid solution in the 300-400 milligram range would be likely to approach the maximum antiviral effect," said Dr. Alan W. Dunton, chief executive. "Our new study design should allow us to see antiviral response data from that dose range later this year."

Based on this dose escalation plan, Panacos said it expects to initiate pivotal trials of bevirimat in 2008.

Shares of Panacos rose 18 cents, or 4.4 percent, to close at $4.25 on the

PANC : did just what I was looking for it ended the day +.33.
Now don't think I'm a big winner here,, I'll let you know how I trade this one. When I first bought this stock @4.30 after it fell from FDA ruling I look at the risk/reward ratio on this and decided to buy 100 shares. If it continues to fall I can let it fall .50 and lose only $50.00 or it could go back up and to fill gap and make over $100.00 which would be about 25% return and could possible become more. Lets see how long it will take for the 5.50 gap to fill.
With todays run I think my reward will outdo the risk as planed.
Reason for the run
-
AP
Panacos, FDA Agree on Revised Study
Monday March 12, 5:16 pm ET 
Panacos Pharma to Move on With Studies for Bevirimat After FDA Agreement on Revised Study

WATERTOWN, Mass. (AP) -- Biotechnology company Panacos Pharmaceuticals Inc. said Monday it has agreed with the Food and Drug Administration on a revised trial design for a midstage study of HIV drug candidate bevirimat.

The drug previously failed to meet expectations in a midstage study testing a high dose. The next part of the Phase IIb clinical trial will test tolerability and effectiveness at increasing doses using an oral liquid form. Dosing on the next cohort will involve 8 patients on the drug and 2 on placebo, starting at 250 milligrams. The doses will be escalated in later groups by 50 milligrams each following safety reviews.

"Models relating antiviral response to drug levels based on earlier bevirimat clinical data indicated that doses of the liquid solution in the 300-400 milligram range would be likely to approach the maximum antiviral effect," said Dr. Alan W. Dunton, chief executive. "Our new study design should allow us to see antiviral response data from that dose range later this year."

STSI : put this one on your watchlist for today

ZL : ZARLINK SEMICONDUCTOR INC
This one was hot today,,over 1,000,000 shares traded and has 3 mon.average of 192,750 and last PR was Mar.1st. Something seems to be brewing.

Quote from: wrangler on March 12, 2007, 12:26:08 PM
BIOM ; bought @1.07
HYGS : bought @1.05
Both stocks is setting at support and trading on low volume. Will post chart
for both tonight with plan.
Goodluck trading

Here's chart for HYGS,,will post chart for BIOM in a little while   

Second leg of the big W might be ready to begin forming. Still holding
HYGS
BIOM
PANC
Quote from" Stock Market Wizard"
The Big W

Double Bottoms provide visual reference points that map the entire reversal process. Once located, these signposts identify most key price pivots and flash early warning signals when violated. The most common of these, The Big W, begins at the last major high printed by a downtrending stock, just prior to the first bottom. The first bounce after this low creates the center of the W as it retraces between 38% and 62% of that last downward move. 
This rally fades and price descends back toward a test of the last bottom low. At this moment the trader listens closely for the first bell to ring. A wide range reversal bar (doji or hammer) may appear close to the low price of the last bottom. Or volume spikes sharply but price does not fail. Better yet, a Turtle Reversal develops where price violates the last low by a few ticks and then prints a sharp move back above support. Should any or all of these events occur, we mark the potential second leg on our Big W. 
Trade entry can be initiated aggressively near the bottom of the second leg if the bells ring loudly. The top of the shorter move marking the partial retracement of the last downward impulse (middle of the W) now becomes our main pivot price for analysis and further trade entry. For price to successfully return to this point, it must retrace 100% of the last fall (from the second low). This finally breaks the lower high, lower low bear cycle. In strong DBs, price will quickly surge to this price right off the second bottom. 

A less aggressive long position can be entered when this new impulse retraces strongly through 62% of the fall into the second low. However, if a short-term exit is desired, sufficient profit potential must exist between the entry and the pivot price for this trade to make sense. Longer-term traders can hold positions as price mounts this pivot. At this point, it will often pause to test support. However, another upward leg is then expected.
















 
 
 
 
 
 

SMSI  -  Break Out
Smith Micro Software, Inc. and its subsidiaries engage in the
development and marketing of wireless communication software products and
services in the United States.

Still holding
PANC
HYGS
BIOM

Be sure to add this one to your watchlist.
NFI
if this company can sell all or part if its loan portfolio and/or secure additional financing it will pop (Check out the massive short interest over 40%).
Share Statistics 
Average Volume (3 month)3: 4,367,900
Average Volume (10 day)3: 5,435,460
Shares Outstanding: 37.41M
Float: 34.26M
% Held by Insiders4: 10.80%
% Held by Institutions4: 36.90%
Shares Short (as of 12-Feb-07)3: 15.24M
Short Ratio (as of 12-Feb-07)3: 8.6
Short % of Float (as of 12-Feb-07)3: 43.90% Shares Short (prior month)3: 12.92M
stocks with high short-interest ratios, or short interest relative to average trading volume. The higher a stock's short-interest ratio, the higher its share price tends to jump during a squeeze

Quote from: wrangler on March 28, 2007, 08:34:05 AM
Be sure to add this one to your watchlist.
NFI
if this company can sell all or part if its loan portfolio and/or secure additional financing it will pop (Check out the massive short interest over 40%).
Share Statistics 
Average Volume (3 month)3: 4,367,900
Average Volume (10 day)3: 5,435,460
Shares Outstanding: 37.41M
Float: 34.26M
% Held by Insiders4: 10.80%
% Held by Institutions4: 36.90%
Shares Short (as of 12-Feb-07)3: 15.24M
Short Ratio (as of 12-Feb-07)3: 8.6
Short % of Float (as of 12-Feb-07)3: 43.90% Shares Short (prior month)3: 12.92M
stocks with high short-interest ratios, or short interest relative to average trading volume. The higher a stock's short-interest ratio, the higher its share price tends to jump during a squeeze

Bought NFI today @4.90. Now I'll wait for pop and short squeeze to begin
Sold PANC
Still holding
HYGS
BIOM
Also bought TVIA today @.38

Hi Wrangler,
NFI is up at premarket.
I was just wondering what you saw yesterday that made you buy NFI at 4.90?

Quote from: Ares on March 29, 2007, 09:13:42 AM
Hi Wrangler,
NFI is up at premarket.
I was just wondering what you saw yesterday that made you buy NFI at 4.90?

Hi ares,,just got in from work,,Thursday is a long day for me
  Only reason for buying I stated in thread about how much short percent of the float is. It doesn't take much of a pop and the shorts will be forced to cover and that will only make it go higher forcing more shorts to cover.
Notice how it done found the support. Now just wait for any kind of good news and pop will begin forcing shorts to cover. Today looks like maybe the shorts is getting nervous and probably selling before it pops.
Goodluck trading

Quote from: wrangler on March 28, 2007, 08:34:05 AM
Be sure to add this one to your watchlist.
NFI
if this company can sell all or part if its loan portfolio and/or secure additional financing it will pop (Check out the massive short interest over 40%).
Share Statistics 
Average Volume (3 month)3: 4,367,900
Average Volume (10 day)3: 5,435,460
Shares Outstanding: 37.41M
Float: 34.26M
% Held by Insiders4: 10.80%
% Held by Institutions4: 36.90%
Shares Short (as of 12-Feb-07)3: 15.24M
Short Ratio (as of 12-Feb-07)3: 8.6
Short % of Float (as of 12-Feb-07)3: 43.90% Shares Short (prior month)3: 12.92M
stocks with high short-interest ratios, or short interest relative to average trading volume. The higher a stock's short-interest ratio, the higher its share price tends to jump during a squeeze

Short % of float was just revised,,lookwhat it is now as of March 12th. This stock is getting ready to take off like a rocket.
Share Statistics 
Average Volume (3 month)3: 4,401,070
Average Volume (10 day)3: 4,616,630
Shares Outstanding: 37.41M
Float: 34.26M
% Held by Insiders4: 10.80%
% Held by Institutions4: 36.90%
Shares Short (as of 12-Mar-07)3: 18.92M
Short Ratio (as of 12-Mar-07)3: 2.8
Short % of Float (as of 12-Mar-07)3: 54.50% Shares Short (prior month)3: 15.24M